Optimizing antibiotic treatment for ventilator-associated pneumonia - PubMed (original) (raw)
Review
Optimizing antibiotic treatment for ventilator-associated pneumonia
Scott T Micek et al. Pharmacotherapy. 2006 Feb.
Abstract
Ventilator-associated pneumonia (VAP) is the most common infectious complication in patients receiving mechanical ventilation and accounts for exorbitant use of resources in the intensive care unit. Antimicrobial management of VAP incorporates an initial broad-spectrum, empiric regimen to ensure appropriate coverage with deescalation of therapy after 48-72 hours based on culture results and sensitivities. When VAP clinically responds to treatment, antimicrobials should be discontinued after 7-8 days to reduce overall antibiotic consumption and the selection pressure on flora observed in the intensive care unit and thus minimize the development and spread of antimicrobial resistance.
Similar articles
- Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779].
Damas P, Garweg C, Monchi M, Nys M, Canivet JL, Ledoux D, Preiser JC. Damas P, et al. Crit Care. 2006;10(2):R52. doi: 10.1186/cc4879. Crit Care. 2006. PMID: 16569261 Free PMC article. Clinical Trial. - Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections.
Koontz CS, Chang MC, Meredith JW. Koontz CS, et al. Am Surg. 2000 Dec;66(12):1110-4; discussion 1114-5. Am Surg. 2000. PMID: 11149581 - [Management of ventilator acquired pneumonia].
Boyadjiev I, Leone M, Garnier F, Albanèse J, Martin C. Boyadjiev I, et al. Ann Fr Anesth Reanim. 2006 Jul;25(7):761-72. doi: 10.1016/j.annfar.2006.03.001. Epub 2006 May 11. Ann Fr Anesth Reanim. 2006. PMID: 16697138 Review. French. - The microbiology of ventilator-associated pneumonia.
Park DR. Park DR. Respir Care. 2005 Jun;50(6):742-63; discussion 763-5. Respir Care. 2005. PMID: 15913466 Review. - Current concepts in the prevention and treatment of ventilator-associated pneumonia.
Micek ST, Skrupky LP. Micek ST, et al. J Pharm Pract. 2010 Feb;23(1):25-32. doi: 10.1177/0897190009356553. J Pharm Pract. 2010. PMID: 21507790 Review.
Cited by
- [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].
Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schröder S. Hochreiter M, et al. Anaesthesist. 2008 Jun;57(6):571-7. doi: 10.1007/s00101-008-1379-x. Anaesthesist. 2008. PMID: 18463831 Clinical Trial. German. - Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Prokocimer P, Bien P, Surber J, Mehra P, DeAnda C, Bulitta JB, Corey GR. Prokocimer P, et al. Antimicrob Agents Chemother. 2011 Feb;55(2):583-92. doi: 10.1128/AAC.00076-10. Epub 2010 Nov 29. Antimicrob Agents Chemother. 2011. PMID: 21115795 Free PMC article. Clinical Trial. - Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Hochreiter M, et al. Crit Care. 2009;13(3):R83. doi: 10.1186/cc7903. Epub 2009 Jun 3. Crit Care. 2009. PMID: 19493352 Free PMC article. Clinical Trial. - Multiresistant bacteria and current therapy - the economical side of the story.
Wilke MH. Wilke MH. Eur J Med Res. 2010 Nov 30;15(12):571-6. doi: 10.1186/2047-783x-15-12-571. Eur J Med Res. 2010. PMID: 21163732 Free PMC article. Review. - Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T. Schroeder S, et al. Langenbecks Arch Surg. 2009 Mar;394(2):221-6. doi: 10.1007/s00423-008-0432-1. Epub 2008 Nov 26. Langenbecks Arch Surg. 2009. PMID: 19034493 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical